Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients

J Clin Psychopharmacol. 2007 Dec;27(6):703-5. doi: 10.1097/jcp.0b013e31815a884d.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use
  • Diagnostic and Statistical Manual of Mental Disorders
  • Dibenzothiazepines / pharmacology
  • Dibenzothiazepines / therapeutic use*
  • Dopamine D2 Receptor Antagonists
  • Dose-Response Relationship, Drug
  • Electroencephalography / methods
  • Humans
  • Male
  • Middle Aged
  • Polysomnography / methods
  • Quetiapine Fumarate
  • Reproducibility of Results
  • Risperidone / therapeutic use*
  • Sample Size
  • Schizophrenia / drug therapy*
  • Sleep / drug effects*
  • Sleep / physiology
  • Sleep, REM / drug effects
  • Sleep, REM / physiology

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Dopamine D2 Receptor Antagonists
  • Quetiapine Fumarate
  • Risperidone